Literature DB >> 8181064

Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide.

S M Pascal1, A U Singer, G Gish, T Yamazaki, S E Shoelson, T Pawson, L E Kay, J D Forman-Kay.   

Abstract

The solution structure of the C-terminal SH2 domain of phospholipase C-gamma 1 (PLC-gamma 1), in complex with a phosphopeptide corresponding to its Tyr-1021 high affinity binding site on the platelet-derived growth factor receptor, has been determined by nuclear magnetic resonance spectroscopy. The topology of the SH2-phosphopeptide complex is similar to previously reported Src and Lck SH2 complexes. However, the binding site for residues C-terminal to the phosphotyrosine (pTyr) is an extended groove that contacts peptide residues at the +1 to +6 positions relative to the pTyr. This striking difference from Src and Lck reflects the fact that the PLC-gamma 1 complex involves binding of a phosphopeptide with predominantly hydrophobic residues C-terminal to the pTyr and therefore serves as a prototype for a second class of SH2-phosphopeptide interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181064     DOI: 10.1016/0092-8674(94)90160-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  49 in total

1.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  Analysis of deuterium relaxation-derived methyl axis order parameters and correlation with local structure.

Authors:  A Mittermaier; L E Kay; J D Forman-Kay
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.835

3.  Loops govern SH2 domain specificity by controlling access to binding pockets.

Authors:  Tomonori Kaneko; Haiming Huang; Bing Zhao; Lei Li; Huadong Liu; Courtney K Voss; Chenggang Wu; Martin R Schiller; Shawn Shun-Cheng Li
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

4.  Intramolecular regulation of phospholipase C-gamma1 by its C-terminal Src homology 2 domain.

Authors:  Karen DeBell; Laurie Graham; Ilona Reischl; Carmen Serrano; Ezio Bonvini; Barbara Rellahan
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

5.  Direct methods and residue type specific isotope labeling in NMR structure determination and model-driven sequential assignment.

Authors:  Andreas Schedlbauer; Renate Auer; Karin Ledolter; Martin Tollinger; Karin Kloiber; Roman Lichtenecker; Simon Ruedisser; Ulrich Hommel; Walther Schmid; Robert Konrat; Georg Kontaxis
Journal:  J Biomol NMR       Date:  2008-09-02       Impact factor: 2.835

6.  A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.

Authors:  Alexis Kaushansky; Andrew Gordus; Bryan Chang; John Rush; Gavin MacBeath
Journal:  Mol Biosyst       Date:  2008-04-08

7.  Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor.

Authors:  M M Zhou; R P Meadows; T M Logan; H S Yoon; W S Wade; K S Ravichandran; S J Burakoff; S W Fesik
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

9.  Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1.

Authors:  Lie Min; Raji E Joseph; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

10.  Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.

Authors:  Paul J Scharf; Jill Witney; Roger Daly; Barbara A Lyons
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.